Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2002
03/26/2002US6362371 β2- adrenergic receptor agonists
03/26/2002US6362335 Process for the preparation of 2-amino-5,8-dimethoxy(1,2,4)triazolo(1,5c)pyrimidine
03/26/2002US6362334 Phthalamide compounds
03/26/2002US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use
03/26/2002US6362191 Aminometyl oxooxazolidinyl benzene derivatives
03/26/2002US6362186 Aminoalkyl substituted 9H-phridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
03/26/2002US6362180 Antagonist to corticotropin releasing factor
03/26/2002US6362178 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
03/26/2002US6362177 Cyclic amine derivatives and their use as drugs
03/26/2002US6362175 Porphyrin compounds for imaging tissue oxygen
03/26/2002US6361594 One-step process using crystal growth inhibitors during synthesis; no size reduction needed; high dispersability, tinctorial strength, purity, and migration, heat, light and weathering fastness
03/21/2002WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022607A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022606A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022605A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022604A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022603A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022602A2 Triazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022601A1 Pyrazole compounds useful as protein kinase inhibitors
03/21/2002WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors
03/21/2002WO2001096341A3 Fungicidal triazolopyrimid-7-ylideneamines
03/21/2002WO2001081346A3 Inhibitors of human phosphatidyl-inositol 3-kinase delta
03/21/2002WO2001066099A3 Use of quinazoline derivatives as angiogenesis inhibitors
03/21/2002WO2001064197A3 Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
03/21/2002US20020035262 7-hetero-bicyclo[2.2.1]-heptanes
03/21/2002US20020035258 Quinolone carboxylic acid derivatives
03/21/2002US20020035251 Antiproliferative agents
03/21/2002US20020035110 Treatment or prevention of disorders of the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, and sleep apnea
03/21/2002US20020035077 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
03/21/2002US20020033192 Trans beta substituted chlorins and methods of making and using the same
03/21/2002DE10045530A1 Kombinatorische Herstellung einer Substanzbibliothek unter Abtrennung einer zwitterionischen Verbindung durch Fällung Combinatorial preparation of a compound library with removal of a zwitterionic compound by precipitation
03/20/2002EP1188732A2 Combinatorial synthesis of a chemical library involving the separation of a zwitterionic compound by precipitation
03/20/2002EP1187835A1 Optically active quinoline carboxylic acid derivatives having 7-pyrrolidine substitutes causing optical activity and a process for preparing thereof
03/20/2002EP0970074B1 Method and compositions for the synthesis of dioxolane nucleosides with beta-configuration
03/20/2002EP0960110B1 3-ARYL SUBSTITUTED PYRAZOLO 4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF 1?) SPECIFIC LIGANDS
03/20/2002EP0888356B1 Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
03/20/2002EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES
03/20/2002CN1341078A Synthetic porous crystalline MCM-68, its synthesis and use
03/19/2002US6359144 Biosynthesis; screening
03/19/2002US6359122 Quinacridone, indigo, dioxazine or azo dyes
03/19/2002US6358964 Adenosine, A3 receptor modulators
03/19/2002US6358954 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
03/19/2002US6358951 Administering pyrazolo(4,3-c)pyridine derivative to treat obesity, congestive heart failure, osteoporosis, aging, bone and muscular disorders
03/19/2002US6358950 Administering (1,5-a)-pyrazolo-1,3,5-triazine derivatives as anxiolytic agents and antidepressants; corticotropin releasing factor antagonists; cardiovascular, autoimmune, nervous system, eating, and psychological disorders
03/19/2002US6358750 Spiro[pyrrolidine-2,3′-oxindole] compounds and method of use
03/19/2002US6358634 Nitrogen-containing heterocyclic compound, organic light-emitting device material and organic light-emitting device
03/19/2002CA2251453C 5-arylalkyl-substituted pyrazolo(4,3-d)pyrimidine-7-ones
03/19/2002CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments
03/14/2002WO2002020527A1 Soluble compounds for the inhibition of multidrug resistance and pharmaceutical compositions thereof
03/14/2002WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
03/14/2002WO2002020525A2 Protein tyrosine phosphatase inhibitor
03/14/2002WO2002020513A1 Oxindole derivatives
03/14/2002WO2002020495A2 Inhibitors of glycogen synthase kinase 3
03/14/2002WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/14/2002WO2002020484A1 Chemical compounds
03/14/2002WO2002020437A2 Basic compounds containing tertiary amides with activity on tachykinin receptors, and pharmaceutical compositions containing them
03/14/2002WO2002020058A1 Preparations for oral administration
03/14/2002WO2001047932A3 Microbicidal effect of porphyrines in darkness
03/14/2002WO2001047918A3 Azolyalkyl-oxa(di)azolyl pyri(mi)dine derivatives, a method for their production and their use as pesticides
03/14/2002WO2001037629A3 High surface microporous materials which are active in oxidation reactions. tiq-6 and metiq-6
03/14/2002US20020032348 Bactericides; reacting imine, carbamate, ester, amide and epoxide derivatives
03/14/2002US20020032329 Method for the preparation of tetrahydrobenzothiepines
03/14/2002US20020032194 CRF receptor antagonists and methods relating thereto
03/14/2002US20020031736 Silver halide color photographic light-sensitive material, pyrrolotriazole compound and dye-forming compound
03/14/2002CA2421718A1 Protein tyrosine phosphatase inhibitor
03/14/2002CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
03/14/2002CA2417177A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/13/2002EP1186607A1 Optically active pyrrolopyridazine compounds
03/13/2002EP1185536A2 Hemisynthetic method and intermediates thereof
03/13/2002EP1185532A1 Peroxynitrite decomposition catalysts and methods of use thereof
03/13/2002EP1185531A1 Cationic pyrrolo-pyrrol-derivatives, method for producing them and colorants for keratin fibres, containing these compounds
03/13/2002EP1185530A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
03/13/2002EP1185529A1 Pyrazolobenzodiazepines as cdk2 inhibitors
03/13/2002EP1185493A1 Quinones for treatment of diseases
03/13/2002EP1185275A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
03/13/2002EP0858452B1 Thiazole derivative as protein kinase c inhibitors
03/12/2002US6355810 Multibinding inhibitors of HMG-CoA reductase
03/12/2002US6355805 β3-adrenergic receptor agonists
03/12/2002US6355799 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
03/12/2002US6355798 Ligands for gamma-aminobutyric acid receptors; anticonvulsants, anxiolytic agents
03/12/2002US6355793 Organometallic zeolite made of multiplicity of units, each of which is symmetrical porphine coordinated to metal ion and substituted with at least two linking groups and optionally with one or more non-linking groups
03/12/2002US6355641 Oxazolone derivatives and uses thereof
03/12/2002US6355638 Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition
03/12/2002CA2055947C Condensed heterocyclic compounds, their production and use
03/07/2002WO2002019213A2 Method for treatment of migraine using pde5 inhibitors
03/07/2002WO2002018455A1 Resins having vinyl ether linker for the solid phase organic synthesis
03/07/2002WO2002018387A1 2,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones with an anticonvulsive action and methods for producing the same
03/07/2002WO2002018386A1 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a]PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a]PYRIMIDIN-5(1H)ONE DERIVATI VES
03/07/2002WO2002018385A1 1-[ALKYL], 1-[(HETEROARYL)ALKYL] AND 1-[(ARYL)ALKYL]-7-PYRIDINYL-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES
03/07/2002WO2002018371A1 Nucleoside metabolism inhibitors
03/07/2002WO2002018344A1 Novel ester or amide derivatives
03/07/2002WO2002018327A2 Guanidinobenzamides as mc4-r agonists
03/07/2002WO2002017925A1 Non-symmetric tripyrrannes in the synthesis of novel macrocycles
03/07/2002WO2002017914A2 Fused pyrrolocarbazoles against inflammation
03/07/2002WO2002017910A1 Agents for neutron capture therapy
03/07/2002WO2002017908A1 Novel metallotexaphyrin derivatives
03/07/2002WO2002017712A2 Disubstituted benzenes as insecticides
03/07/2002WO2001064678A3 Inhibitors of hepatitis c virus ns3 protease
03/07/2002WO2001064226A3 Farnesyl protein transferase inhibitor combinations with platinum compounds
03/07/2002WO2001055131A3 Prodigiosin-derivatives as neoplastic and anti-viral agents